10-Q: Superior Group Reports Q3 Profit Halves Amid Sales Decline

Superior Group of Companies, Inc. reported a significant decline in net income and EBITDA for the third quarter and first nine months of 2025, driven by decreased sales across all segments and lower gross margins.

Summary

• Net income for the three months ended September 30, 2025, decreased by 49.2% to $2.7 million, down from $5.4 million in the prior year period.
• Consolidated net sales for the third quarter fell by 7.5% to $138.5 million, compared to $149.7 million in the same period last year, with declines across all three segments.
• EBITDA for the third quarter decreased by 35.3% to $7.5 million, down from $11.7 million in the prior year.
• For the nine months ended September 30, 2025, net income decreased by 64.3% to $3.5 million, from $9.9 million in the comparable period of 2024.
• Nine-month consolidated net sales slightly decreased by 0.2% to $419.6 million, compared to $420.3 million in the prior year, primarily due to declines in Healthcare Apparel and Contact Centers.
• Gross margin rate for the third quarter was 38.3%, down from 40.4% in the prior year, and for the nine months was 37.9%, down from 39.6%.
• Net cash provided by operating activities for the nine months ended September 30, 2025, was $1.3 million, a significant decrease from $24.5 million in the prior year period.
• Total debt increased to $100.0 million as of September 30, 2025, from $86.0 million as of December 31, 2024, primarily due to increased borrowings under the revolving credit facility.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant declines in net income, EBITDA, and operating cash flow, coupled with decreasing sales across all segments and lower gross margins. While management is addressing costs and maintaining liquidity, substantial external risks from tariffs, trade agreement expirations, and macroeconomic headwinds persist, indicating a challenging operating environment.

Positives

• Interest expense, net, decreased by 12.2% for the three months and 20.9% for the nine months ended September 30, 2025, due to a lower weighted average interest rate on borrowings (5.4% in 2025 vs. 6.3% in Q3 2024 and 6.5% in 9M 2024).
• Selling and administrative expenses as a percentage of net sales remained stable at 35.0% for the three months ended September 30, 2025, compared to the prior year.
• The Branded Products segment saw a 1.3% increase in net sales for the nine months ended September 30, 2025, primarily driven by a $9.1 million contribution from the 3Point acquisition in December 2024.
• The company was in compliance with its debt covenants (fixed charge coverage ratio of at least 1.25 to 1.0 and a net leverage ratio not to exceed 4.0 to 1.0) as of September 30, 2025.
• Management concluded that disclosure controls and procedures were effective as of September 30, 2025, with no material changes in internal control over financial reporting.

Negatives

• Net income decreased by 49.2% for the three months and 64.3% for the nine months ended September 30, 2025.
• Consolidated net sales decreased by 7.5% for the three months ended September 30, 2025, with all segments experiencing declines (Branded Products -8.1%, Healthcare Apparel -4.6%, Contact Centers -9.5%).
• Consolidated gross margin rate declined to 38.3% in Q3 2025 from 40.4% in Q3 2024, and to 37.9% for the nine months from 39.6% in 9M 2024, due to customer sales mix, product cost reductions in prior year, higher agent costs, and tariff costs.
• Net cash provided by operating activities significantly decreased to $1.3 million for the nine months ended September 30, 2025, from $24.5 million in the prior year, largely due to $10.5 million cash outflows for inventory purchases.
• Inventory balances increased to $105.7 million as of September 30, 2025, from $96.7 million at December 31, 2024, attributed to sales decreases in Healthcare Apparel and timing of purchases.
• The Contact Centers segment continues to face macroeconomic headwinds, leading to client downsizing and attrition outpacing new customer acquisitions, and the closure of its Jamaica contact center on June 15, 2025, impacted gross margin mix.
• Healthcare Apparel segment experienced volume decreases within existing customer accounts and higher tariff costs ($0.6 million for nine months) in advance of price increases.

Risks

• The imposition of higher and/or new tariffs by the U.S. government on materials and production, particularly from China and Vietnam, could materially adversely impact revenue, operations, financial position, and cash flows.
• Expiration of U.S. trade agreements and preferences (AGOA, HOPE, HELP) on September 30, 2025, if not renewed, could negatively impact costs of doing business in affected countries (e.g., Haiti) or necessitate moving sourcing and manufacturing.
• Civil unrest in countries where products are manufactured, such as Haiti, may result in facility damage, interrupt manufacturing processes, and adversely affect reputation and customer relationships.
• Prolonged or recurring disruptions in the global political and economic environment could lead to reduced demand, declines in revenue and profitability, increased compliance costs, stock price declines, less favorable borrowing terms, negative impacts on pension valuations, reduced customer creditworthiness, and potential impairment of intangible assets.
• Uncertainty regarding how inflation and interest rates will be impacted by tariffs and other trade actions during the remainder of 2025.

Future Outlook

The company anticipates continued macroeconomic headwinds impacting its Contact Centers segment, leading to client downsizing and attrition. It is actively monitoring the impact of higher tariffs and the expiration of key trade agreements (AGOA, HOPE, HELP) on its sourcing and manufacturing costs, which could necessitate moving production to countries with more favorable cost structures if not renewed. The company expects to continue paying dividends and executing its share repurchase program as financial conditions permit, while evaluating the future impacts of the One Big Beautiful Bill Act (OBBBA) on its financial statements.

Management Comments

• Michael Koempel, President & Chief Financial Officer, certified that the Quarterly Report on Form 10-Q does not contain any untrue statement of a material fact or omit to state a material fact, and that the financial statements fairly present the financial condition, results of operations, and cash flows.
• Michael Benstock, Chief Executive Officer, and Michael Koempel, Chief Financial Officer, concluded that the company's disclosure controls and procedures were effective as of September 30, 2025.
• Management believes that the combination of current cash levels, cash flows from operating activities, and availability under the revolving credit facility will be sufficient to satisfy capital requirements for the next twelve months and beyond.

Industry Context

The company's Contact Centers segment is experiencing challenges due to broader macroeconomic headwinds, which are causing client downsizing and attrition, reflecting a difficult environment for business process outsourcing services. The Branded Products and Healthcare Apparel segments are navigating increased tariffs and the expiration of significant trade agreements, which could lead to higher product costs or necessitate shifts in global supply chains, impacting the apparel and promotional products industries. The overall environment suggests a cautious outlook for companies reliant on global manufacturing and BPO services.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• The company is involved in various legal actions and claims arising from the normal course of business, which are not expected to have a material adverse effect on its financial position, results of operations, or cash flows.

Stakeholder Impact

• Shareholders: Experienced a significant decrease in net income and EPS, but dividends are being maintained, and a share repurchase program is in place, potentially offering some support to share value.
• Employees: Headcount reductions contributed to lower selling and administrative expenses in some segments, indicating potential job impacts.
• Customers: May face potential price increases due to higher tariff costs, particularly in the Healthcare Apparel segment.
• Suppliers: The company is evaluating sourcing alternatives due to tariffs and expiring trade agreements, which could shift business away from current suppliers in affected regions.
• Creditors: The company remains in compliance with debt covenants, indicating continued financial stability relative to its debt obligations, despite increased total debt.

Next Steps

• Monitor imposed tariffs and duties, related ongoing negotiations, and the status of trade agreements and preferences involving the U.S. government and sourcing/manufacturing countries.
• Evaluate the future impacts of the One Big Beautiful Bill Act (OBBBA) on consolidated financial statements.
• Continue to pay cash dividends in the future as financial conditions permit.
• Execute the $17.5 million share repurchase program under the 10b5-1 trading plan, which commenced September 20, 2025, until the repurchase limit is reached or other specified events occur.
• Continue to evaluate the capital expenditure program in light of prevailing economic conditions.

Key Dates

Recommendation

The company faces significant headwinds, including substantial declines in net income and EBITDA, decreasing sales across segments, and lower gross margins. External risks from tariffs, expiring trade agreements, and macroeconomic conditions are pronounced. However, management is actively managing costs, maintaining liquidity, and continuing shareholder returns through dividends and a share repurchase program. The stock may already reflect some of these challenges. A 'hold' recommendation suggests that while there are clear negative trends and risks, the company's efforts to stabilize and its commitment to shareholder returns warrant observing further developments rather than immediate divestment, assuming the current valuation adequately discounts the known issues.

Keywords

Superior Group of Companies, SGC, Quarterly Report, Earnings, Financial Results, Branded Products, Healthcare Apparel, Contact Centers, Uniforms, Promotional Products, BPO, SEC Filing, 10-Q, Tariffs, Trade Agreements, Operating Income, EBITDA, Net Sales, Gross Margin, Cash Flow, Share Repurchase, Dividends